122 related articles for article (PubMed ID: 15175645)
1. Conservation of the genomic structure and receptor-mediated signaling between human and rat IL-24.
Wang M; Tan Z; Thomas EK; Liang P
Genes Immun; 2004 Aug; 5(5):363-70. PubMed ID: 15175645
[TBL] [Abstract][Full Text] [Related]
2. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
Chada S; Mhashilkar AM; Ramesh R; Mumm JB; Sutton RB; Bocangel D; Zheng M; Grimm EA; Ekmekcioglu S
Mol Ther; 2004 Dec; 10(6):1085-95. PubMed ID: 15564140
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of mda-7/IL-24 receptors in liver cancer cell lines.
Zhu H; Yang ZB
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):402-6. PubMed ID: 19666410
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of mouse IL-22 binding protein.
Wei CC; Ho TW; Liang WG; Chen GY; Chang MS
Genes Immun; 2003 Apr; 4(3):204-11. PubMed ID: 12700595
[TBL] [Abstract][Full Text] [Related]
5. Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice.
Tachiiri A; Imamura R; Wang Y; Fukui M; Umemura M; Suda T
Genes Immun; 2003 Mar; 4(2):153-9. PubMed ID: 12618864
[TBL] [Abstract][Full Text] [Related]
6. Cytokine and tumor cell apoptosis inducing activity of mda-7/IL-24.
Gopalkrishnan RV; Sauane M; Fisher PB
Int Immunopharmacol; 2004 May; 4(5):635-47. PubMed ID: 15120649
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway.
Li TS; Li XN; Chang ZJ; Fu XY; Liu L
Cell Signal; 2006 Aug; 18(8):1287-98. PubMed ID: 16310341
[TBL] [Abstract][Full Text] [Related]
8. IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22.
Wu PW; Li J; Kodangattil SR; Luxenberg DP; Bennett F; Martino M; Collins M; Dunussi-Joannopoulos K; Gill DS; Wolfman NM; Fouser LA
J Mol Biol; 2008 Oct; 382(5):1168-83. PubMed ID: 18675824
[TBL] [Abstract][Full Text] [Related]
9. MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
Chada S; Sutton RB; Ekmekcioglu S; Ellerhorst J; Mumm JB; Leitner WW; Yang HY; Sahin AA; Hunt KK; Fuson KL; Poìndexter N; Roth JA; Ramesh R; Grimm EA; Mhashilkar AM
Int Immunopharmacol; 2004 May; 4(5):649-67. PubMed ID: 15120650
[TBL] [Abstract][Full Text] [Related]
10. Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart.
Weiss B; Wolk K; Grünberg BH; Volk HD; Sterry W; Asadullah K; Sabat R
Genes Immun; 2004 Aug; 5(5):330-6. PubMed ID: 15201862
[TBL] [Abstract][Full Text] [Related]
11. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
Chada S; Bocangel D; Ramesh R; Grimm EA; Mumm JB; Mhashilkar AM; Zheng M
Mol Ther; 2005 May; 11(5):724-33. PubMed ID: 15851011
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein.
Sauane M; Gopalkrishnan RV; Choo HT; Gupta P; Lebedeva IV; Yacoub A; Dent P; Fisher PB
Oncogene; 2004 Oct; 23(46):7679-90. PubMed ID: 15334067
[TBL] [Abstract][Full Text] [Related]
13. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-24 and its receptors.
Wang M; Liang P
Immunology; 2005 Feb; 114(2):166-70. PubMed ID: 15667561
[TBL] [Abstract][Full Text] [Related]
15. Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2.
Li J; Tomkinson KN; Tan XY; Wu P; Yan G; Spaulding V; Deng B; Annis-Freeman B; Heveron K; Zollner R; De Zutter G; Wright JF; Crawford TK; Liu W; Jacobs KA; Wolfman NM; Ling V; Pittman DD; Veldman GM; Fouser LA
Int Immunopharmacol; 2004 May; 4(5):693-708. PubMed ID: 15120653
[TBL] [Abstract][Full Text] [Related]
16. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
[TBL] [Abstract][Full Text] [Related]
17. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism.
Bleicher L; de Moura PR; Watanabe L; Colau D; Dumoutier L; Renauld JC; Polikarpov I
FEBS Lett; 2008 Sep; 582(20):2985-92. PubMed ID: 18675809
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2.
Wang M; Tan Z; Zhang R; Kotenko SV; Liang P
J Biol Chem; 2002 Mar; 277(9):7341-7. PubMed ID: 11706020
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.
Strengell M; Julkunen I; Matikainen S
J Leukoc Biol; 2004 Aug; 76(2):416-22. PubMed ID: 15178704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
